Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension | Revista Portuguesa de Cardiologia (English edition)

Statistics

Original Article

Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension

Efeitos miocárdicos e anti-inflamatórios da terapêutica crónica com bosentan na hipertensão pulmonar experimental

Dulce Fontouraa,1, José Oliveira-Pintoa,1, Marta Tavares-Silvaa,b, Sara Leitea, Francisco Vasques-Nóvoaa,c, Pedro Mendes-Ferreiraa, André P. Lourençoa,d,

Corresponding author

aplourenco@yahoo.com

Corresponding author.

, Adelino F. Leite-Moreiraa,e

a Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal

b Department of Cardiology, São João Hospital Centre, E.P.E., Porto, Portugal

c Department of Internal Medicine, São João Hospital Centre, E.P.E., Porto, Portugal

d Department of Anaesthesiology, São João Hospital Centre, E.P.E., Porto, Portugal

e Department Cardiothoracic Surgery, São João Hospital Centre, E.P.E., Porto, Portugal

Read

9470

Times
was read the article

2583

Total PDF

6887

Total HTML

Share statistics

Article information

ISSN: 08702551
Original language: English

DOI:10.1016/j.repc.2013.09.016

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 11	66	42	108
2025 10	71	47	118
2025 9	76	37	113
2025 8	55	24	79
2025 7	79	36	115
2025 6	57	27	84
2025 5	60	23	83
2025 4	62	32	94
2025 3	66	15	81
2025 2	39	37	76
2025 1	50	33	83
2024 12	53	26	79
2024 11	61	41	102
2024 10	44	36	80
2024 9	51	35	86
2024 8	44	31	75
2024 7	36	31	67
2024 6	34	28	62
2024 5	54	20	74
2024 4	38	28	66
2024 3	47	19	66
2024 2	52	37	89
2024 1	43	38	81
2023 12	28	29	57
2023 11	39	25	64
2023 10	23	27	50
2023 9	34	16	50
2023 8	25	22	47
2023 7	31	9	40
2023 6	40	12	52
2023 5	41	32	73
2023 4	24	3	27
2023 3	27	23	50
2023 2	42	12	54
2023 1	42	20	62
2022 12	55	23	78
2022 11	59	31	90
2022 10	36	9	45
2022 9	31	34	65
2022 8	30	34	64
2022 7	35	42	77
2022 6	31	21	52
2022 5	29	41	70
2022 4	35	28	63
2022 3	24	31	55
2022 2	28	22	50
2022 1	26	24	50
2021 12	28	28	56
2021 11	37	40	77
2021 10	34	34	68
2021 9	33	34	67
2021 8	28	35	63
2021 7	21	24	45
2021 6	24	23	47
2021 5	38	35	73
2021 4	53	34	87
2021 3	89	17	106
2021 2	69	9	78
2021 1	37	15	52
2020 12	31	8	39
2020 11	36	17	53
2020 10	30	16	46
2020 9	44	15	59
2020 8	31	9	40
2020 7	51	13	64
2020 6	45	8	53
2020 5	48	8	56
2020 4	44	16	60
2020 3	53	11	64
2020 2	181	15	196
2020 1	35	8	43
2019 12	46	8	54
2019 11	30	4	34
2019 10	25	3	28
2019 9	35	14	49
2019 8	29	4	33
2019 7	41	10	51
2019 6	28	7	35
2019 5	48	11	59
2019 4	26	18	44
2019 3	29	16	45
2019 2	43	10	53
2019 1	26	8	34
2018 12	39	10	49
2018 11	210	9	219
2018 10	676	8	684
2018 9	140	9	149
2018 8	85	11	96
2018 7	27	14	41
2018 6	38	7	45
2018 5	46	13	59
2018 4	34	15	49
2018 3	62	10	72
2018 2	32	4	36
2018 1	37	6	43
2017 12	51	10	61
2017 11	35	15	50
2017 10	29	10	39
2017 9	39	8	47
2017 8	47	15	62
2017 7	39	14	53
2017 6	55	13	68
2017 5	54	7	61
2017 4	34	3	37
2017 3	32	35	67
2017 2	19	6	25
2017 1	43	7	50
2016 12	20	12	32
2016 11	22	2	24
2016 10	18	8	26
2016 9	17	5	22
2016 8	10	1	11
2016 7	2	3	5
2016 6	7	6	13
2016 4	29	5	34
2016 3	61	22	83
2016 2	73	27	100
2016 1	52	27	79
2015 12	75	18	93
2015 11	59	18	77
2015 10	46	13	59
2015 9	54	14	68
2015 8	55	9	64
2015 7	77	14	91
2015 6	45	12	57
2015 5	48	10	58
2015 4	49	16	65
2015 3	45	9	54
2015 2	44	6	50
2015 1	36	20	56
2014 12	56	13	69
2014 11	52	14	66
2014 10	83	17	100
2014 9	47	15	62
2014 8	62	23	85
2014 7	58	25	83
2014 6	74	44	118
2014 5	29	18	47

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter